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ABSTRACT
For DNA replication to occur, chromatin must be
remodeled. Yet, we know very little about which
proteins alter nucleosome occupancy at origins
and replication forks and for what aspects of repli-
cation they are required. Here, we demonstrate that
the BRG1 catalytic subunit of mammalian SWI/
SNF-related complexes co-localizes with origin
recognition complexes, GINS complexes, and
proliferating cell nuclear antigen at sites of DNA rep-
lication on extended chromatin fibers. The specific
pattern of BRG1 occupancy suggests it does not
participate in origin selection but is involved in
the firing of origins and the process of replication
elongation. This latter function is confirmed by the
fact that Brg1 mutant mouse embryos and RNAi
knockdown cells exhibit a 50% reduction in replica-
tion fork progression rates, which is associated with
decreased cell proliferation. This novel function
of BRG1 is consistent with its requirement during
embryogenesis and its role as a tumor suppressor
to maintain genome stability and prevent cancer.
INTRODUCTION
DNA replication occurs during S-phase of the cell cycle to
duplicate each chromosome into two sister chromatids
with a high degree of ﬁdelity. As a prerequisite, a highly
coordinated series of biochemical events must occur from
early G1 to the G1-S-phase transition. During early G1, six
ORC proteins assemble as origin recognition complexes
(ORCs) at origins of replication throughout the genome
at  25-kb intervals (1). In mammalian cells, these sites
are presumably determined epigenetically because they
are ubiquitous and do not share a consensus DNA
sequence. Not all origins are competent to initiate replica-
tion, but many are licensed to do so when minichro-
mosome maintenance (MCM) complex proteins 2–7 are
loaded in an ORC1/Cdc6- and Cdt1-dependent manner
to form pre-replicative complexes (pre-RCs) (2). At the
G1-S-phase transition, CDC7 and CDK2 promote the
recruitment of CDC45 and GINS complexes to a subset
of pre-RCs, now considered pre-initiation complexes
(pre-ICs), leading to activation of the MCM helicase,
which collaborates with at least 20 additional cell-cycle
proteins to initiate DNA replication in a bi-directional
manner (3,4). Some initiation factors are also crucial for
elongation. For example, proliferating cell nuclear antigen
(PCNA) functions as a trimeric clamp that surrounds the
DNA to increase DNA polymerase processivity and rep-
lication fork progression. All of the aforementioned steps
culminate in replicons of  60–100kb, which are unevenly
distributed throughout the genome but emanate from
every second or third origin on average (5,6). Finally,
 10 neighboring replicons often coalesce as  1Mb
replication foci.
DNA replication is undoubtedly much more com-
plicated than portrayed by current working models, as
described above, because the replication machinery must
interact with a nucleosomal template rather than naked
DNA. For example, the molecular basis for selecting
origins of replication in mammalian cells is not known
because they do not share a common DNA sequence,
but nucleosome phasing and covalent histone modiﬁca-
tions are leading candidates. Histone acetylation is a
particularly good candidate for the timing of DNA repli-
cation because licensed origins that ﬁre early during
S phase, such as gene-rich segments, tend to be
hyperacetylated, whereas late-replicating sites such as het-
erochromatic regions are often hypoacetylated (7,8). This
correlation is compelling for numerous genes that undergo
X chromosome inactivation (XCI), genomic imprinting or
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gin that is in close proximity to a promoter will be
hyperacetylated, replicate early, and be transcribed; in
contrast, the identical DNA sequence on the homologous
chromosome will be hypoacetylated, replicate late, and
not be transcribed (10,11). This process appears to be
complicated, involving Mbp intervals of DNA changing
subnuclear position (12). It is also not clear whether tran-
scription inﬂuences replication timing or vice versa in
these cases (9,13). However, replication asynchrony is
ﬁrst observed during early embryonic development,
which precedes the monoallelic expression that usually
occurs much later in more differentiated cell types [e.g.,
imprinted genes in the placenta and central nervous
system (CNS), odorant receptors in olfactory epithelium,
IgH in B cells] (9). Therefore, the effect of histone acetyl-
ation on replication timing is apparently direct or at least
not secondary to transcription.
Chromatin is also an impediment to DNA polymerases
and must be remodeled for efﬁcient replication fork
progression (14). Following the removal of H1 linker
histones, which allows 30-nm solenoid structures to
unravel into 10-nm nucleosomal arrays, histone
octamers are removed in a two-step process just ahead
of the fork. H2A-H2B dimers are removed by ‘facilitates
chromatin transcription’ (FACT) and then H3–H4 tetra-
mers are removed by ASF1 (anti-silencing function 1)
(14). Both of these histone chaperones directly (FACT)
or indirectly (ASF1) interact with the MCMs, which
might contribute to their recruitment to sites of DNA rep-
lication (14,15). In addition to acting as histone acceptors,
FACT and ASF1 probably act as histone donors by
interacting with CAF1 (chromatin assembly factor 1) to
redeposit histone octamers onto sister chromatids imme-
diately behind the replication fork (16). Both recycled
parental histones and newly synthesized histones contrib-
ute to these newly formed nucleosomes (17,18).
Identiﬁcation and characterization of chromatin-
modifying factors that participate in DNA replication
will greatly increase our understanding of how this
process occurs efﬁciently in the condensed chromatin en-
vironment of the interphase nucleus. SWI/SNF-related
complexes are good candidates because of their well-
characterized role in nucleosome remodeling (19–22).
These 1–2MDa complexes are recruited to speciﬁc sites
in the genome and confer DNA-dependent ATPase
activity to break DNA–histone contacts and alter nucleo-
some conformation and/or position (23). For example,
when recruited to promoters by sequence-speciﬁc tran-
scription factors, SWI/SNF-related complexes can slide
or evict nucleosomes away from transcription start sites
to enable RNA polymerase II to initiate transcription.
Although the vast majority of SWI/SNF-related studies
have focused on transcriptional regulation, this does
not exclude them from playing a role in DNA replication.
For instance, FACT and ASF1 also function in transcrip-
tion, and transcriptional data have been drawn upon
to provide insight into their function in replication (14).
More importantly, SWI/SNF was ﬁrst discovered in
Saccharomyces cerevisiae where it is required for efﬁcient
replication of at least one autonomous replication
sequence (24), which is equivalent to an origin of replica-
tion, and swi/snf mutant strains grow slowly (20–22).
In addition, remodels structure of chromatin (RSC)
complexes are similar to SWI/SNF in their biochemical
composition and activity but are 10-fold more abundant
and essential for yeast viability (20–22).
Similarly, mammalian SWI/SNF-related complexes
are essential based on null mutations of the BRG1
(brahma-related gene 1, also known as SMARCA4)
catalytic ATPase or two other core subunits (BAF155
and SNF5/BAF47) as well as one non-core subunit
(BAF250) that each confer early embryonic lethality in
mice (19,22,25,26). To circumvent this lethality, which
precludes a functional assessment of their role in tran-
scription and replication, we previously used ethyl-
nitrosourea (ENU) to generate a Brg1 hypomorphic
mutation in the mouse. This Brg1
ENU1 mutant allele
encodes a BRG1 protein with an E1083G substitution in
the catalytic ATPase domain that is stable and assembles
into SWI/SNF-related complexes (27). However, it has
diminished chromatin-remodeling properties, and
Brg1
null/ENU1 mutants die at midgestation due to severe
anemia. Utilizing these mutants, we have previously
deﬁned the role of BRG1 in chromatin remodeling/
looping and transcription of the a and b globin loci
(27–30) and now report a novel function for BRG1 in
DNA replication.
MATERIALS AND METHODS
Mice, BrdU and histology
All mouse experiments were performed using protocols
approved by the Institutional Animal Care and Use
Committees (IACUC) of UNC and in accordance with
federal guidelines. Timed matings were initiated, and
BrdU was injected i.p. (0.1mg per gram body weight)
12 days after detection of a copulation plug. Embryos
were removed 2–4h after the injection, ﬁxed in
4% paraformaldehyde, and processed for the production
of parafﬁn sections. Sections (5–8mm) were stained with a
BrdU staining Kit (Zymed) or stained with hematoxylin
and eosin (H&E).
Flow cytometry/sorting
Flow cytometry was performed as previously described
(27). Brieﬂy, fetal livers (FLs) were triturated in
phosphate-buffered saline (PBS) containing 2% fetal
bovine serum (FBS) using 1-cc syringes ﬁtted with
needles having progressively smaller apertures (18, 22
and 25 gauges). Approximately 2 10
6 cells were
incubated with anti-KIT-FITC, anti-TER119-PE and
Annexin V-APC (each from Pharmingen) on wet ice in
the dark for 1h. Cells were washed several times and
analyzed using FACScan and MoFlow instruments
(Becton Dickinson). For each experiment, wild-type cells
were also incubated with each antibody alone as well as no
antibody or Annexin V to serve as compensation controls.
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RNA was prepared using Trizol reagent (Invitrogen) and
reverse-transcribed using a mixture of random hexamers
and Oligo d(T) (BioRad iScript) according to standard
procedures. Validated TaqMan assays (Applied
Biosystems) were used with TaqMan gene expression
master mix (Applied Biosystems) on an ABI7300 instru-
ment under default cycling conditions (95 C 15s followed
by 60 C 1min for 45 cycles). Gapdh was used as a normal-
ization control. Relative expression levels were determined
using the Ct method.
Plasmids and transfections/RNA interference
The methodology for knocking down BRG1 in MiaPaCa2
cells and BRM in LNCaP have already been described
(31,32). For the D98OR HeLa knockdown cells, which
have BRG1 and BRM reductions, we ﬁrst established a
stable cell line (D98OR Brg1i-11) with BRG1 knocked
down using an identical procedure as for the MiaPaCa2
cells (31).
All transfections were performed using Lipofectamine
2000
TM (Invitrogen) per the manufacturer’s instructions
on cells that had been equally plated in 100mm culture
plates for stable transfections. Cells were plated in
antibiotic-free media and allowed to attain 70–80%
conﬂuency in a 37 C/5% CO2-supplemented/100%
humidity incubator prior to transfection. pHTPBrmi and
pcDNA3 (Invitrogen, CMV driven with G418 resistance
gene) were transfected into D98orBrg1-11 using a total of
40ng of DNA in a respective 5:1 ratio. Transfectant
material was replaced after 24h with fresh RPMI 1640
supplemented with 10% FBS. After 24h, the cells were
released by trypsin-treatment and equally divided among
8–100-mm culture plates. For selection, puromycin (2mg/
ml) and G418 (1mg/ml) was applied and maintained for
10–21 days after which single colony clones were captured,
isolated in 24-well plates, and allow to mature. Protein
was harvested and western blots run to verify the status
of the target proteins as described (31).
Nucleotide analog labeling of DNA
For chromatin ﬁber studies, EdU was added to NHF1
and SW13 cultures at a ﬁnal concentration of 30mM. For
FL cells, pregnant mice were injected i.p. with 420mlo f
10mM EdU. FLs were removed and placed on ice
between 15 and 25min after injection. For DNA ﬁber
studies, pregnant mice were injected i.p. with 20mM
IdU and after 11min they were then injected i.p. with
100mM CldU. FLs were removed and placed on ice
5min after injection. For the tissue culture studies,
D98OR or Mia PaCa2 cells were incubated with IdU
at a ﬁnal concentration of 50mM for 10min, washed
with PBS twice and then incubated with CldU at a
ﬁnal concentration of 100mM for 20min. Afterwards,
the cells were washed and prepared for DNA ﬁber
analysis.
DNA ﬁber studies
For the preparation of the DNA ﬁber spreads upon slides,
2ml of a 200cell/ml cell suspension were spread on a
SILANEPREP
TM slide (Sigma-Aldrich, S4651), close
and parallel to the label. The sample was allowed to
evaporate until almost, but not completely dry and then
overlaid with 10ml of spreading buffer [0.5% SDS in
200mM Tris–HCl (pH 7.4), 50mM EDTA]. After
 10min the slide was tilted at  15  to allow the cell
lysate to slowly move down the slide, and the resulting
DNA spreads were air-dried, ﬁxed in 3:1 methanol/acetic
acid for 2min, air-dried overnight, then stored at  20 C
for at least 24h. The staining of the IdU and CldU tracks
(red and green, respectively) in the DNA ﬁbers were per-
formed as described previously (33–36). Microscopy was
carried out using an Olympus FV500 confocal microscope
using the sequential scanning mode.
Statistical analyses
In the experiments comparing replication track lengths,
statistical signiﬁcance was determined using Student’s
two-tailed t-test.
Extended chromatin ﬁber studies
Extended chromatin ﬁbers were prepared and immuno-
ﬂuorescence was performed essentially as previously
described (37). Brieﬂy, cells were pelleted and resuspended
in warm hypotonic buffer (0.075M KCl) at 37 C for
20min. After hypotonic buffer treatment, approximately
8000 cells were cytospun onto Superfrost Plus slides
(Fisher Scientiﬁc). After removal of excess ﬂuid, 20ml
of a lysis buffer (25mM Tris, pH 7.5, 0.5M NaCl,
0.75% Triton X-100, and 0.2M urea) that contains
40,6-diamidino-2-phenylindole (DAPI; Sigma, 0.2mg/ml)
was added and the liquid immediately covered with a
22 22mm square coverslip. Slides were incubated over-
night protected from light. DAPI staining allowed for the
visualization of chromatin ﬁbers and slides were chosen
for further processing based on the quality of chromatin
ﬁber extension.
Primary antibodies and dilutions used: BRG1 (G-7)
diluted 1:50, ORC1 (N-17) diluted 1:100, PCNA
(FL-261) diluted 1:200, all from Santa Cruz
Biotechnology Inc., Santa Cruz CA; ORC2 diluted
1:200, Stressgen Bioreagents Victoria BC; PSF2
(1:2000) from Abcam Inc., Cambridge MA; acetyl-H3
(1:100), Upstate Cell Signaling Solutions, Temecula,
CA. Anti-BRG1 (J1) was diluted 1:100 was a generous
gift from Drs. W. Wang and J. Crabtree. Secondary
antibodies were diluted 1:200 and were Alexa Fluor con-
jugates purchased from Invitrogen. All incubations were
conducted in a moist chamber at room temperature.
Microscopy was carried out using an Olympus FV500
confocal microscope using the sequential scanning mode.
Photomicrographic images were analyzed using Image
J software (Rasband, W.S., ImageJ, National Institutes
of Health, Bethesda, Maryland, USA, 1997-2004) with
UCSD (http://rsb.info.nih.gov/ij/plugins/ucsd.html) and
McMaster Photobionics (Colocalization Highlighter;
6908 Nucleic Acids Research, 2010,Vol.38, No. 20Pierre Bourdoncle, Institut Jacques Monod, Service
Imagerie) plugins. Results were analyzed and graphed
using Microsoft Excel 2007.
Co-IP experiment
Immunoprecipitations were performed on E12.5 FL cells
using anti-BRG1 (J1) as previously described (30).
Western blots were performed using a TOPBP1 antibody
(Signal Transduction Laboratories) as described (38).
RESULTS
BRG1 regulates cell proliferation during development
The overall body size of Brg1
null/ENU1 mutants at embry-
onic day (E) 12.5 is smaller than wild-type controls
(Figure 1A). Mutant FLs are particularly small based on
gross anatomical examination as well as H&E staining of
parasagittal sections (Figure 1A and B). Dissection of
mutant FLs highlights their pallor and decreased size
(Figure 1C). We previously demonstrated that the pallor
is a result of reduced a and b globin transcription and
fewer hemoglobin-containing cells due to a partial devel-
opmental block at the transition from basophilic erythro-
blasts to polychromatic erythroblasts (Figure 1D). To
quantify the smaller size of mutant FLs, we performed
cell counts and determined that they have a  3-fold
reduction in cell number (Figure 1E).
The decreased number of mutant FL cells could be due
to decreased cell proliferation and/or increased apoptosis
so we performed bromodeoxyuridine (BrdU) incorpor-
ation and Annexin V assays, respectively. BrdU incorpor-
ation was markedly reduced in mutant FLs (Figure 1F),
and quantiﬁcation at high magniﬁcation revealed a 2- to
3-fold decrease (Figure 1G), which is consistent with the
decreased cell number. In contrast, no difference was
observed for Annexin V staining using ﬂow cytometry
(Figure 1H and I). These experiments utilized two cell-
surface markers: 1, KIT, a stem/progenitor cell marker
of multiple hematopoietic lineages (including erythroid);
2, TER119, a pan-erythroid marker. Due to the partial
developmental block, mutants have a normal number of
KIT-positive cells (Figure 1H, right side) but a decreased
number of KIT-negative cells (Figure 1H, left side).
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Figure 1. BRG1 regulates cell proliferation in erythroid cells of the fetal liver. (A) Photograph comparing wild-type (WT) and mutant (Mut) E12.5
embryos. (B) Parasagittal sections from WT and Mut E12.5 embryos stained with H&E. The sections are in the optimal focal plane for visualizing
the FLs, which are outlined by boxes. (C) Photograph of FLs removed from E12.5 embryos. (D) Schematic of the erythroid lineage in the FL from
undifferentiated (left) to differentiated (right). HSC, hematopoietic stem cell; BFU-E, burst forming unit-erythroid; CFU-E, colony forming
unit-erythroid; E, proerythroblast; B, basophilic erythroblast; P, polychromatic erythroblast; O, orthochromatic erythroblast; N, non-nucleated
reticulocyte. Beneath each cell type is the expression status of the cell-surface markers KIT (a marker of hematopoietic progenitors) and TER119
(a pan-erythoid marker). (E) Hemocytometer-based cell counts of WT and Mut FLs. (F) BrdU incorporation of WT and Mut E12.5 embryos using
sections adjacent to those shown in (B). FLs are outlined by boxes. (G) Percentage of BrdU-positive cells from WT and Mut E12.5 FLs. (H) Flow
cytometry of E12.5 FLs showing the Annexin V status of KIT-positive and –negative cells. (I) Flow cytometry of E12.5 FLs showing the Annexin V
status of TER119-postive and -negative cells.
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polychromatic erythroblasts, orthochromatic erythro-
blasts and reticulocytes (Figure 1D) and are
underrepresented in mutants (Figure 1I, right side).
However, Annexin V is not elevated in either KIT- or
TER119-positive mutant cells, indicating that the mutant
cells were not undergoing apoptosis more frequently than
normal (Figure 1H and I). In addition, we did not detect a
difference in trypan blue vital dye staining (data not
shown), which indicated the mutant cells were not under-
going necrosis. These results indicate that BRG1 regulates
cell proliferation but not cell death in the FL.
The Brg1 mutant phenotype is most severe in the
erythroid lineage because Brm is not expressed and
cannot compensate
The cell proliferation defect in Brg1 mutants is more
severe in the FL than other cell types of the E12.5
embryo. One explanation is that erythroid cells of the
FL proliferate more rapidly than most or all other
tissues at this stage of development. A second explanation,
which is not mutually exclusive, relates to functional re-
dundancy. We reasoned that Brm, which encodes an al-
ternative catalytic subunit 75% identical to BRG1 with
similar nucleosome remodeling properties, might func-
tionally compensate in most embryonic cell types but
not in the FL. To test this hypothesis, we compared
Brg1 and Brm mRNA levels by reverse transcription
quantitative polymerase chain reaction (RT-qPCR).
Brg1 is expressed at high levels in TER119 ﬂow-sorted
erythroid cells of the FL with mRNA levels  10-fold
greater than the rest of the embryo (Figure 2A). In
contrast, Brm is not expressed in TER119 cells but is
strongly expressed in the rest of the embryo (Figure 2A).
In fact, Brm mRNA levels are nearly 3-fold higher than
Brg1 in the whole embryo (Figure 2B). A survey of adult
tissues also showed that Brm expression is as high or
higher than Brg1 in each organ that was analyzed
(Supplementary Figure 1). These results indicate that
erythroid cells of the FL are unusual because Brm is not
expressed, and, as a corollary, suggest that these cells
exhibit a particularly severe phenotype in Brg1 mutants
because Brm cannot compensate.
BRG1 is required for efﬁcient replication
fork progression
BRG1 activates transcription of cyclin-dependent kinase
inhibitors (p16
INK4A and p21
CIP1/WAF1) and physically as-
sociates with retinoblastoma (RB) to inhibit cell-cycle pro-
gression in vitro (39–46). However, it is not known
whether this mechanism is signiﬁcant in vivo. For
example, based on our previous gene expression proﬁling
experiments on ﬂow-sorted erythroid cells from wild-type
versus mutant FLs, we did not identify any genes in the
RB pathway or other cell-cycle regulatory factors as can-
didates to explain the cell proliferation phenotype
described above (27). In addition, the gene expression
proﬁles of Brg1 mutant mammary tumors, which are
heterogeneous in nature, do not exhibit altered expression
of cell-cycle genes in the RB pathway (47).
Therefore, we hypothesized that BRG1 might not
function as a transcriptional regulator in this context but
instead plays a more direct role in the process of DNA
replication. To analyze the dynamics of DNA replication,
two ﬂuorescently labeled nucleotide analogs were sequen-
tially incorporated into E12.5 embryos in vivo, and DNA
ﬁbers were subsequently prepared from dissected FLs and
visualized by confocal microscopy (Figure 3A). Adding
two analogs sequentially allowed us to determine the dir-
ectionality of replication and to identify origins of repli-
cation as well as continuing and terminating replication
forks (33,36). We did not observe a signiﬁcant difference
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Figure 2. Brm is not expressed in erythroid cells of the fetal liver. (A) RT-qPCR analysis of Brg1 and Brm mRNA levels normalized to Gapdh levels
in wild-type ﬂow-sorted erythroid cells (TER119+) and whole mouse embryos minus their fetal livers (embryo) at E12.5. The white histograms on the
left show Brg1 expression of embryos relative to TER119+samples. The gray asterisk on the right indicates Brm mRNA levels are below the limit of
detection in TER119+samples and is compared to Brm expression in embryoss (gray histogram). Each histogram represents the mean±SE for two
(TER119+) or three (embryo) independent experiments. (B) Brm mRNA levels relative to Brg1 mRNA levels based on data presented in (A). For
TER119+(left) and embryo samples (right), Brg1 mRNA levels (white histograms) are set at 1.0 and Brm mRNA levels (gray asterisk/histogram) are
shown in proportion. The asterisk indicates Brm was analyzed for TER119 samples but mRNA was not detected.
6910 Nucleic Acids Research, 2010,Vol.38, No. 20in the relative ratio of replication intermediates (ori-
gin initiations, active replication forks or forks that
terminated) between wild-type and mutant samples, sug-
gesting that there is no difference in replication compe-
tency (Supplementary Figure 2).
However, these experiments did demonstrate that
replication forks from wild-type samples incorporated sig-
niﬁcantly more IdU and CldU than mutant samples
(Figure 3B). Quantiﬁcation of track lengths revealed a
20-kb average length for wild-type samples compared to
a 10-kb average for mutants (Figure 3C). This method
provides an accurate measurement of DNA replication
rate: decreased track length of mutant cells is due to
reduced incorporation of nucleotide analogs into nascent
DNA during the labeling interval (33). These data indicate
Brg1 mutants have a 50% reduction in the rate of
replication fork progression. Notably, RNAi-mediated
knockdown of factors required for replication fork
stability such as timeless, claspin and Chk1 also result in
a  50% reduction of fork progression (36,48).
To rule out the possibility that the altered cellularity of
mutant FLs is responsible for their decreased replication
fork progression, we repeated our DNA ﬁber experiments
on independent samples that were isolated as speciﬁc
cell populations using ﬂow sorting. Following IdU and
CldU incorporation in vivo, FLs from several WT and
mutant E12.5 embryos were pooled and stained with
KIT and TER119 to obtain three distinct populations:
KIT-positive cells (i.e. hematopoietic stem and progenitor
cells), KIT/TER119 double-positive cells (i.e. proerythro-
blasts and basophilic erythroblasts) and TER119-positive
cells (i.e. orthochromatic and polychromatic erythro-
blasts, and reticulocytes although they lack nuclei
and will not incorporate IdU or CldU) as depicted sche-
matically in Figure 1D. In each of these cell types, similar
to whole FLs, fork progression rates are decreased
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Figure 3. BRG1 is required for efﬁcient replication fork progression. (A) Schematic of the procedure. Pregnant female mice are injected i.p. with
ﬂuorescently labeled IdU (red) followed by CldU (green), E12.5 embryos are removed, FLs are dissected and single-cell suspensions are spotted onto
microscope slides. The FL cells are lysed and confocal microscopy is utilized to visualize newly synthesized DNA as pulse-labeled tracks of IdU (red)
and CldU (green) incorporation. (B) Representative confocal image of WT and Mut DNA ﬁbers showing decreased track lengths in Muts.
(C) Quantiﬁcation of track lengths from over 200 DNA ﬁbers derived from multiple WT controls (numbered 1 and 2) and Muts (numbered 1, 2
and 3) with average values also presented. The Muts have a signiﬁcantly smaller track lengths than WT controls (P<0.0001). (D) Track lengths of
Mut relative to WT for ﬂow-sorted cell populations from FLs. (E) Knockdown of BRG1 decreases replication progression rates in D98OR HeLa
cells (P<0.0001) and MiaPaCa2 cells (P<0.014). Chart shows the relative lengths of replication tracks in parental (P) and knockdown (KD) cells.
(F, G) Genetic perturbation of BRG1 results in decreased inter-origin distances. (F) Illustration of the criteria used to measure inter-origin distances.
(G) Quantiﬁcation of inter-origin distances in WT and Mut FL cells or parental (P) and knockdown (KD) D98OR cells. At least 25 inter-origin
distances were measured in each sample. Error bars in (C–E) and (G) represent standard errors of the mean.
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that BRG1 is required for efﬁcient replication fork
progression.
To further conﬁrm that BRG1 is required for efﬁcient
replication fork progression, we repeated our DNA ﬁber
experiments using an independent experimental system.
For these experiments, we performed RNAi to
knockdown BRG1 in a HeLa cell subclone (D98OR)
and a human pancreatic carcinoma cell line deﬁcient for
BRM (MiaPaCa2) (31,49). BRM was also knocked down
in the D98OR cells to prevent it from compensating and
to resemble the situation in FL cells, which do not express
BRM (Figure 2). Western blot analysis demonstrated a
robust knockdown (Supplementary Figure 3). Compared
to parental controls, the knockdown cells had a  50%
and  20% reduction in replication fork progression in
the D98OR and MiaPaCa2, respectively (Figure 3E).
The D98OR knockdown phenocopies the FL results.
Many licensed replication origins are not utilized during
S phase, but remain dormant and thus the region in which
they reside is replicated by neighboring origins (50–52).
These dormant origins can be activated when replication
is inhibited or slowed and become essential for the
completion of replication and cell survival (53–57). The
activation of dormant origins can be inferred when
the average distance between origins (the inter-origin
distance) decreases (56,57). We wondered whether
mutant FL cells or D98OR cells lacking BRG1 and
BRM have a decreased inter-origin distance as compared
to controls since these cells replicate slower. In each case,
we found that the cells lacking BRG1 and BRM had a
reduced inter-origin distance ( 35% and  45%, respect-
ively) (Figure 3F). This decrease in inter-origin distance
suggests that cells lacking BRG1 and BRM try to com-
pensate for the reduced rate of replication by initiating
more origins and increasing the density of replication
forks.
BRG1 co-localizes with replication factors at sites of
DNA replication on extended chromatin ﬁbers
We recently analyzed the distribution of ORCs, GINS
complex proteins, and PCNA at high resolution by per-
forming immunoﬂuorescence (IF) confocal microscopy on
extended chromatin ﬁbers (37). To determine whether
BRG1 is involved in DNA replication, we used this
same methodology to evaluate the distribution of BRG1
relative to these DNA replication associated proteins.
Control experiments demonstrated that two different
BRG1 antibodies co-localize on extended chromatin
ﬁbers from normal human ﬁbroblasts (NHF1-hTERT
cells) (Supplementary Figure 4A). We also demonstrated,
as a negative control, a lack of BRG1 staining on extended
chromatin ﬁbers prepared from the BRG1-deﬁcient
SW13 cancer cell line (Supplementary Figure 4B). The
BRG1 antibody used for the rest of this study (Santa
Cruz G-7) has been used on western blots by many
groups including our own to demonstrate it is absolutely
speciﬁc (27).
Next, we analyzed extended chromatin ﬁbers from
E12.5 FLs and identiﬁed signiﬁcant overlap between
BRG1 and ORC1 (Figure 4A) as well as between BRG1
and PCNA at sites of DNA replication (Figure 4B). To
detect active sites of DNA replication, the nucleotide
analog EdU was injected i.p. into pregnant female mice
and incorporated into E12.5 embryos immediately before
FLs were dissected and processed. EdU was used for these
studies because, unlike IdU and CldU, sites of incorpor-
ation can be detected without removing chromatin-bound
proteins or denaturing the DNA. Overall, ORC1
co-localized with BRG1 35% the time, while BRG1
co-localized with ORC1 68% of the time (11 ﬁbers,
 59Mb). BRG1 co-localized even more strongly with
PCNA (Figure 4B), and this co-localization was highly
enriched at sites of DNA replication based on the
presence of EdU (Figure 4B). Measurement of extended
chromatin ﬁbers from mouse FLs revealed that PCNA
and BRG1 signal co-localized 84% of the time at sites
of replication (14 ﬁbers,  70Mb) compared to only
15% at sites not undergoing replication. It is true that
BRG1 is associated with enhancers and promoters in the
context of transcription and that some of these elements
might coincide with origins of replication. However, loci
undergoing DNA replication are not transcribed simul-
taneously [(58) and references within]. Therefore, BRG1
that co-localizes with the replication protein PCNA at
sites of EdU incorporation must be functioning in the
context of DNA replication.
To assess BRG1 occupancy in more detail, we used
normal human ﬁbroblasts (NHF1-hTERT cells) because
of our previous experience visualizing and quantifying
replication proteins on extended chromatin ﬁbers from
these cells. First, we analyzed BRG1 occupancy in com-
parison to ORC1 and tracks of recently replicated DNA
(Figure 5A and B). To detect active sites of DNA replica-
tion, cells were incubated with EdU for 20 or 30min, as
indicated, before being collected. In our previous study,
we found that ORC1 is densely distributed on ﬁbers
before replication begins (presumably cells in G1 and
early S phase) and dissociates from sites after replication
is completed (37). GINS complex proteins and PCNA also
dissociate from chromatin following replication, and this
is thought to prevent re-replication.
The left side of the ﬁber in Figure 5A shows a high
density of ORC1 staining that is typical for sites that
have not yet replicated. Alternatively, the right side of
the same ﬁber has a much sparser distribution of ORC1
and at least one active site of replication (arrow). BRG1
overlap with ORC1 is relatively weak at sites that have not
replicated but relatively strong where DNA replication is
ongoing (the left and right side of the ﬁber in Figure 5A,
respectively). The ﬁber in Figure 5B also has a sparse dis-
tribution of ORC1 that overlaps BRG1 regions, particu-
larly at sites of EdU incorporation. This distribution
pattern suggests BRG1 is not involved in the binding of
ORCs to origins of replication but has a subsequent
function in licensing pre-RCs and/or facilitating the initi-
ation or elongation of replication.
BRG1 was also bound to some sites that likely had
already replicated, as indicated by lack of ORC1
binding, suggesting it participates in a process other than
DNA replication (Figure 5B and Supplementary Figure 5).
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a well-established role in transcriptional regulation. To
quantify the extent of BRG1-ORC1 co-localization, we
analyzed 19 ﬁbers corresponding to  93Mbp of DNA.
BRG1 co-localizes with ORC1 62.8% of the time while
ORC1 co-localizes with BRG1 55.2% of the time (333
BRG1 sites, 374 ORC1 sites). We also compared the dis-
tribution of BRG1 relative to the GINS complex protein
PSF2. As we previously reported (37), GINS complex
proteins are found on chromatin ﬁbers before DNA rep-
lication begins (Figure 5C; absence of EdU staining) and
during DNA replication (Figure 5D; asterisks at sites of
EdU incorporation). The ﬁbers in Figure 5C–E also show
the distribution of BRG1 relative to PSF2. We found that
BRG1 overlaps with PSF2 52% of the time while PSF2
overlaps with BRG1 78% of the time (23 ﬁbers, 118Mb,
376 BRG1 sites, 260 PSF2 sites). This level of
co-localization is nearly as high as the overlap between
two members of the GINS complex (85% for PSF1 and
PSF2) (37). PCNA associates with BRG1 on extended
chromatin ﬁbers at levels similar to PSF2 (Figure 6A
and B). BRG1 overlaps with PCNA 52% of the time,
and PCNA overlaps with BRG1 73% of the time (22
ﬁbers, 132Mb, 408 BRG1 sites, 289 PCNA sites). These
data provide further support that BRG1 in not part of the
pre-RC but is instead part of licensed pre-ICs plus
elongating replication forks.
The ﬁbers shown in Figure 5A–D were from cells
incubated with EdU for 20min. As mentioned above,
when regions complete replication, GINS complex
proteins and PCNA disassociate from chromatin. To de-
termine whether this is also the case for BRG1, we
increased EdU labeling times to 30min (Figured 5E and
6A and B), which gave us a wider range of EdU track
sizes. In the ﬁber shown in Figure 5E, regions with EdU
staining are devoid of PSF2 and BRG1 (arrows),
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Figure 4. BRG1 co-localizes with ORC1 and PCNA at sites of DNA replication on chromatin ﬁbers from mouse fetal liver cells. (A) ORC1 (red
signal) and BRG1 (blue signal) can be seen on this ﬁber and overlap at several sites. EdU (green signal) is not observed on this ﬁber, which is
consistent with the fact that the vast majority of ORCs are bound to DNA in G1 prior to the onset of DNA replication. (B) BRG1 (red signal)
co-localizes with PCNA (blue signal) exclusively at sites of active DNA replication based on EdU incorporation (green signal). Bar  25mm(  400kb;
bottom right of each panel).
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Figure 5. BRG1 co-localizes with ORC1 and PSF2 to different extents on extended chromatin ﬁbers from human ﬁbroblasts. Normal human
ﬁbroblasts were labeled with EdU for 20min (A–D) or 30min (E). Bars  25mm(  400kb; bottom right of each panel). (A) The left side of this
chromatin ﬁber has an abundance of ORC1 (red signal), little BRG1 (blue signal), and no replication tracks. The right side of the ﬁber has several
regions where BRG1 co-localizes with ORC1, including one site that is undergoing DNA replication (green EdU labeling, arrow). (B) This ﬁber has a
higher density of BRG1 than the ﬁber in (A) where DNA replication activity is marked by green EdU labeling. About half of this ﬁber has no bound
ORC1 and most likely represents a region where ORCs have disassociated from the chromatin after DNA replication occurred (prior to the addition
of the EdU label). (C) Both BRG1 (red signal) and the GINS protein PSF2 (blue signal) can be found along this ﬁber but with no EdU, suggesting
that these proteins co-localize on chromatin before DNA replication begins. (D) BRG1, GINS complexes and EdU (green signal, white asterisks) are
all present. The small tracks of EdU co-localize with BRG1 and PSF2. (E) Increased incubation time with EdU allows for the visualization of longer
tracks of newly replicated DNA. Sites of co-localization of BRG1 and PSF2 can still be found, but there are also regions of EdU that are devoid of
these two proteins (arrows). The localization of BRG1, PSF2 and DNA replication tracks on this ﬁber suggests that as DNA replication in a given
replicon is completed, BRG1 and GINS disassociate from chromatin.
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chromatin in these newly replicated regions is similar to
that for PSF2. Likewise, Figure 6A shows that short
tracks of EdU (green EdU staining) still have bound
BRG1 and PCNA, while regions with longer tracks of
newly replicated DNA in Figure 6B (arrows) are devoid
of PCNA and BRG1.
The co-localization of BRG1 with replication factors at
sites of DNA replication suggests BRG1 is at replication
forks. To provide further support for this idea, we
performed co-immunoprecipitation (co-IP) assays. These
experiments demonstrate that BRG1 physically associates
with TOPBP1, which is a component of the replication
fork and a sensor of replication stress (Figure 6C). This
ﬁnding suggests that BRG1 is recruited to DNA replica-
tion forks by TOPBP1, and there is evidence that this
could be mediated by the BRCT domain of TOPBP1
(38). This result is also compatible with BRG1 mutants
having a reduction in replication fork progression since
this is known to trigger replication stress (36,48,59–61).
DISCUSSION
To provide additional insight into the mechanism(s)
of DNA replication, including its role in development
and cancer, it will be necessary to determine the
temporal–spatial and functional relationship between
chromatin-remodeling factors and the DNA replication
machinery. Here, we demonstrate that the BRG1 catalytic
subunit of mammalian SWI/SNF-related complexes is
physically associated with TOPBP1 and co-localizes with
ORCs, GINS complexes and PCNA at sites of DNA
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C
Figure 6. BRG1 co-localizes with PCNA and physically associates with TOPBP1. (A, B) Analysis of BRG1 and PCNA on extended chromatin ﬁbers
from human ﬁbroblasts. Normal human ﬁbroblasts were labeled with EdU for 30min. Bars  25mm(  400kb; bottom right of each panel). (A) Both
BRG1 (red signal) and PCNA (blue signal) can be seen at sites where replication is beginning (green signal, EdU). (B) Longer tracks of newly
replicated DNA can be seen on this ﬁber. Sites of co-localization of BRG1 and PCNA can still be found, but there are also regions of EdU that are
devoid of these two proteins (arrows). (C) BRG1 physically associates with TOPBP1. Shown is a western blot probed with aTOPBP1. Samples
include E12.5 FLs (Input) and protein lysates immunoprecipitated with aBRG1 (BRG1) or IgG as a negative control.
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this approach is that native chromatin is visualized at high
resolution ( 16kb/mm) and the DNA replication status
for speciﬁc regions of the genome (i.e. not started, in
progress or completed) can be determined. As a result,
we are able to conclude that BRG1 does not play a role
in the binding of ORCs to origins of replication, referred
to as site selection, but is instead involved in the ﬁring
of origins and the process of replication elongation.
The latter conclusion is supported by our observation
that the efﬁciency of replication fork progression in Brg1
mutants and knockdown HeLa cells is reduced to 50% of
normal.
Considering that BRG1 breaks DNA–histone contacts
to alter the conformation and position of nucleosomes, we
propose BRG1 changes nucleosome structure at replica-
tion forks to facilitate the removal of H2A–H2B dimers
by FACT and/or H3–H4 tetramers by ASF1. This model
is supported by several lines of evidence. First, BRG1
and other SWI/SNF subunits are present with FACT
in non-canonical WINAC complexes. Second, RSC
complexes cooperate with another histone chaperone,
NAP1 (nucleosome assembly protein 1), to remove
H2A–H2B dimers from nucleosomes in vitro (62). Third,
the Brg1 ortholog snf2 exhibits a genetic interaction with
asf1 in S. cerevisiae based on double mutants exhibiting a
more severe phenotype than either single mutant (63).
Moreover, in Drosophila melanogaster,brahma (brm) and
two other swi/snf genes (swi3/moira/Baf155 and swi1/osa/
Baf250) genetically interact with asf1, and these complexes
associate with ASF1 based on co-IP and GST pull-down
assays (64). These physical associations, along with our
BRG1–TOPBP1 interaction data, provide a plausible ex-
planation for how BRG1 is recruited to sites of replica-
tion. ASF1 is known to bind bromodomain-containing
proteins, and the bromodomains of BRG1 and BAF180
may reinforce binding to sites with acetylated histones
(65,66). Some of our own preliminary data support this
notion. On chromatin ﬁbers from normal human ﬁbro-
blasts during S phase, sites of H3K9 acetylation were
found 70% of the time at sites of BRG1 occupancy
(10 ﬁbers, 47.5Mb, 111 H3K9ac sites, 152 BRG1 sites)
(Supplementary Figure 6). This correlation was even
higher at sites of active replication; 87% of sites with
co-localization of H3K9ac and EdU also had BRG1. It
is also possible that the bromodomains of BRG1 and
BAF180 bind to acetylated lysines on other proteins.
Recent proteomic data indicate BRG1 and other SWI/
SNF subunits are acetylated and replication-associated
protein(s) such as MCMs are frequently acetylated
compared to other proteins (67).
More experiments will be required to determine precise-
ly how BRG1 alters nucleosome conformation and/or
position to promote octamer disassembly at the replica-
tion fork. BRG1 can slide or evict nucleosomes, which is
referred to as cis- and trans-displacement, respectively
(23). BRG1 can also create a small loop of DNA that
protrudes away from the octamer to make the nucleosome
more accessible without moving it; this might be an inter-
mediate step for cis- and trans-displacement, but other
ATPase chromatin remodelers such as SNF2H apparently
cannot perform this function (23). In addition, we and
others have demonstrated recently that BRG1 can form
chromatin loops between enhancers and promoters to
facilitate transcription (29,68,69). Chromatin loops also
have been shown to occur at replication foci during
S phase so BRG1 might be involved in this process as
an additional possibility.
The data presented here demonstrate BRG1 plays a
novel role in a fundamental biological process, DNA rep-
lication, which is compatible with its known function in
embryonic development and cancer prevention. For
example, Brg1 null homozygotes die at the blastocyst
stage just prior to implantation (25). Although it might
have been assumed that this early embryonic lethality is
due to deregulated transcription, it is difﬁcult or impos-
sible to ascertain the relative contribution of defective
transcription and DNA replication. In this regard, it is
notable that null mutations of many replication-associated
genes such as Psf1, which encodes a GINS complex
member, also cause early embryonic lethality (70). The
small size and poor accessibility of the early mouse
embryo make it relatively intractable for molecular
studies, but BRG1 is also dosage sensitive and functions
as a haploinsufﬁcient tumor suppressor. We previously
identiﬁed many copy-number gains (i.e. duplications and
ampliﬁcations) and losses (i.e. deletions) in DNA from
Brg1 null heterozygous mammary tumors (47). We did
not propose that BRG1 maintains genomic stability
because there was not a plausible mechanism and
genomic instability could have been a secondary effect
since it is a general feature of tumors. Considering the
role of BRG1 in replication and the strong links
between DNA replication and repair, however, it seems
likely that BRG1 is, in fact, crucial for the process of
maintaining genome stability. Additional evidence
supports this view. For example, BRG1 also physically
interacts with BRCA1 (71,72). A direct role for BRG1
in replication/repair is further supported by a recent
study that used the Cre/loxP system to generate Brg1
null homozygous ﬁbroblasts (73). Following adenoviral
delivery of Cre, Brg1 mutant cells exhibited decreased
BrdU incorporation, delayed cell-cycle progression and
compromised genome integrity manifest by micronuclei
and aneuploidy. Because these are primary, non-
immortalized/transformed cells as opposed to cancer
cells, it is clear that BRG1 plays a direct role in mainten-
ance of genomic stability. All of these ﬁndings are consist-
ent with recent reports that BRG1 and SWI/SNF-related
complexes are involved in both double-strand break repair
and nucleotide excision repair (74–77). Therefore, when
considering the function of BRG1 in vivo, in both devel-
opment and cancer prevention, one should consider the
DNA replication/repair-based mechanism described here
in addition to transcriptional regulation of downstream
target genes such as those in the RB pathway.
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